Ozempic is the only FDA-approved oral peptide GLP-1 medication for adults with type 2 diabetes indicated not only to improve blood sugar, along with diet and exercise, but also to reduce the risk of major cardiovascular events (MACE) such as heart attack, stroke or death in those who are also at high risk for these events
Improved insulin signaling can support metabolic stability by helping the body regulate glucose more efficiently
In general, the usual dose is one tablet per day, taken with food
The medication produces an agonist (a chemical) that acts as GLP-1 by binding itself to the appropriate cell receptors
According to the Saxenda Summary of Product Characteristics, treatment should be discontinued if less than 5% weight loss is achieved after 12 weeks on the maintenance dose of 3.0 mg daily Blood pressure and heart rate : Saxenda can increase heart rate, so cardiovascular parameters should be monitored regularly Blood glucose levels : Particularly important for patients with type 2 diabetes or prediabetes, as weight loss and GLP-1 agonist effects can improve glycaemic control Lipid profile and other metabolic markers : To assess improvement in cardiovascular risk factors Mental health and wellbeing : Weight loss can affect mood, and any concerns about depression or suicidal thoughts should be reported immediately Managing common gastrointestinal side effects involves eating smaller, more frequent meals, avoiding high-fat foods, staying well-hydrated, and allowing time for your body to adjust to each dose increase
It has almost all of the same effects, while being effective and stable at low concentrations
